By: Nibedita Roy, Sankar Kumar Guchhait, Vaishnavi Newaskar, Abhishek Rai
Conventional broad-spectrum antibiotics often disrupt gut microbiota, causing a range of health issues like inflammatory bowel disease (IBD), secondary infections, colorectal cancer, liver disease, cognitive impairment, diabetes, and obesity. While the ‘one drug treats all’ strategy offers convenience, the l




